In summary, as a selective IKKε inhibitor, MCCK1 is proved to enhance the anticancer effect of TMZ in attenuating the invasion, migration, and EMT of GBM cells in vitro and in vivo. This evidence concerns the gene IKBKE and glioblastoma.